The DOI matches its Crossref record; 197 of the 197 references it cites were found in a registry or an index.
The Role of Inflammation in Cancer: Mechanisms of Tumor Initiation, Progression, and Metastasis
Open accessAbstract
Inflammation is an essential component of the immune response that protects the host against pathogens and facilitates tissue repair. Chronic inflammation is a critical factor in cancer development and progression. It affects every stage of tumor development, from initiation and promotion to invasion and metastasis. Tumors often create an inflammatory microenvironment that induces angiogenesis, immune suppression, and malignant growth. Immune cells within the tumor microenvironment interact actively with cancer cells, which drives progression through complex molecular mechanisms. Chronic inflammation is triggered by factors such as infections, obesity, and environmental toxins and is strongly linked to increased cancer risk. However, acute inflammatory responses can sometimes boost antitumor immunity; thus, inflammation presents both challenges and opportunities for therapeutic intervention. This review examines how inflammation contributes to tumor biology, emphasizing its dual role as a critical factor in tumorigenesis and as a potential therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
de Visser, K. E., & Joyce, J. A. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.016 · Cited by 4,059
Inflammation and cancer: triggers, mechanisms, and consequences
Greten, F. R., & Grivennikov, S. I. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.025 · Cited by 3,806
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121 · cited 2×
“For example, it suppresses growth in patient-derived prostate cancer cells and non-invasive LNCaP cells [45,93–95], whereas aggressive PC3 prostate cancer cells exhibit increased proliferation upon Activin A exposure [69,98].”
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., Isakoff, S. J., Ciciliano, J. C., Wells, M. N., Shah, A. M., et al. (2013) · Science · doi:10.1126/science.1228522 · Cited by 2,476
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
Aceto, N., Bardia, A., Miyamoto, D. T., Donaldson, M. C., Wittner, B. S., Spencer, J. A., Yu, M., Pely, A., Engstrom, A., Zhu, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.013 · Cited by 2,441
Molecular principles of metastasis: a hallmark of cancer revisited
Fares, J., Fares, M. Y., Khachfe, H. H., Salhab, H. A., & Fares, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0134-x · Cited by 2,379
The stress response to trauma and surgery
Desborough, J. P. (2000) · British Journal of Anaesthesia · doi:10.1093/bja/85.1.109 · Cited by 2,296
Noman, M. Z., Desantis, G., Janji, B., Hasmim, M., Karray, S., Dessen, P., Bronte, V., & Chouaib, S. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131916 · Cited by 2,166
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,047
Tumor angiogenesis: causes, consequences, challenges and opportunities
Lugano, R., Ramachandran, M., & Dimberg, A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03351-7 · Cited by 1,986
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
Tumor microenvironment as a therapeutic target in cancer
Xiao, Y., & Yu, D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107753 · Cited by 1,957
Tumor-Associated Macrophages in Tumor Immunity
Pan, Y., Yu, Y., Wang, X., & Zhang, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583084 · Cited by 1,872
Labelle, M., Begum, S., & Hynes, R. O. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.009 · Cited by 1,833
Wang, D., & DuBois, R. N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2809 · Cited by 1,793
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712 · cited 1×
“Hypoxia plays a pivotal role in tumor progression, significantly shaping the tumor microenvironment [40].”
Cytotoxic CD8+ T cells in cancer and cancer immunotherapy
Raskov, H., Orhan, A., Christensen, J. P., & Gögenur, I. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01048-4 · Cited by 1,687
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Carmeliet, P., & Jain, R. K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3455 · Cited by 1,675
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
Dang, E. V., Barbi, J., Yang, H.-Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H.-R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.033 · Cited by 1,595
Epithelial Mesenchymal Transition in Tumor Metastasis
Mittal, V. (2018) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043854 · Cited by 1,528
Every step of the way: integrins in cancer progression and metastasis
Hamidi, H., & Ivaska, J. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0038-z · Cited by 1,493
Endothelial Cell Migration During Angiogenesis
Lamalice, L., Le Boeuf, F., & Huot, J. (2007) · Circulation Research · doi:10.1161/01.res.0000259593.07661.1e · Cited by 1,482
Lactate metabolism in human health and disease
Li, X., Yang, Y., Zhang, B., Lin, X., Fu, X., An, Y., Zou, Y., Wang, J.-X., Wang, Z., & Yu, T. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01151-3 · Cited by 1,454
IL-6 in inflammation, autoimmunity and cancer
Hirano, T. (2021) · International Immunology · doi:10.1093/intimm/dxaa078 · Cited by 1,453 · cited 1×
“This process is further amplified by the recruitment of stromal and immune cells to inflamed tissues, where they secrete additional factors that nurture a tumor-promoting microenvironment [23,24].”
Dungan, K. M., Braithwaite, S. S., & Preiser, J.-C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60553-5 · Cited by 1,431
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M., & Motohashi, H. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.016 · Cited by 1,395 · cited 1×
“By activating enzymes involved in GSH synthesis, including G6PD, TKT, and PGD, through the pentose phosphate pathway (PPP), Nrf2 ensures a steady supply of nucleotides and amino acids essential for sustained cancer cell proliferation [151,152].”
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Facciabene, A., Peng, X., Hagemann, I. S., Balint, K., Barchetti, A., Wang, L.-P., Gimotty, P. A., Gilks, C. B., Lal, P., Zhang, L., et al. (2011) · Nature · doi:10.1038/nature10169 · Cited by 1,376
Immune checkpoint signaling and cancer immunotherapy
He, X., & Xu, C. (2020) · Cell Research · doi:10.1038/s41422-020-0343-4 · Cited by 1,371
Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,337
STING: infection, inflammation and cancer.
Barber, G. N. (2015) · Nature Reviews Immunology · doi:10.1038/nri3921 · Cited by 1,313
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Liu, Z.-L., Chen, H.-H., Zheng, L.-L., Sun, L.-P., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,300
Characteristics and Significance of the Pre-metastatic Niche
Liu, Y., & Cao, X. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.011 · Cited by 1,269
On the Origin of Cancer Metastasis
Seyfried, T. N., & Huysentruyt, L. C. (2013) · Critical Reviews in Oncogenesis · doi:10.1615/critrevoncog.v18.i1-2.40 · Cited by 1,196
Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J.-I., Cheng, P., Cho, H.-I., Celis, E., Quiceno, D. G., Padhya, T., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100587 · Cited by 1,173
Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
Grivennikov, S. I., & Karin, M. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.005 · Cited by 1,160
Immune cell promotion of metastasis
Kitamura, T., Qian, B.-Z., & Pollard, J. W. (2015) · Nature Reviews Immunology · doi:10.1038/nri3789 · Cited by 1,158
Brain tumour cells interconnect to a functional and resistant network
Osswald, M., Jung, E., Sahm, F., Solecki, G., Venkataramani, V., Blaes, J., Weil, S., Horstmann, H., Wiestler, B., Syed, M., et al. (2015) · Nature · doi:10.1038/nature16071 · Cited by 1,143
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Cheng, Y., He, C., Wang, M., Ma, X., Mo, F., Yang, S., Han, J., & Wei, X. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0095-0 · Cited by 1,097 · cited 2×
“While these responses can enhance tumor antigen presentation and stimulate antitumor immunity under certain conditions, they may also paradoxically support tumor survival and therapy resistance by activating prosurvival signaling pathways [21].”
The global burden of cancer: priorities for prevention
Thun, M. J., DeLancey, J. O., Center, M. M., Jemal, A., & Ward, E. M. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp263 · Cited by 1,091
TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression
Yang, L., Pang, Y., & Moses, H. L. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.04.002 · Cited by 1,023
Neutrophils support lung colonization of metastasis-initiating breast cancer cells
Wculek, S. K., & Malanchi, I. (2015) · Nature · doi:10.1038/nature16140 · Cited by 1,003
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors
Moeller, B. J., Cao, Y., Li, C. Y., & Dewhirst, M. W. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00115-1 · Cited by 996
Reactive Oxygen Species: Drivers of Physiological and Pathological Processes
Checa, J., & Aran, J. M. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s275595 · Cited by 984
Clinton, S. K., Giovannucci, E. L., & Hursting, S. D. (2020) · The Journal of Nutrition · doi:10.1093/jn/nxz268 · Cited by 973
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
Schito, L., & Semenza, G. L. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.10.016 · Cited by 962
Pathophysiological consequences of VEGF-induced vascular permeability
Weis, S. M., & Cheresh, D. A. (2005) · Nature · doi:10.1038/nature03987 · Cited by 909
E-cadherin is required for metastasis in multiple models of breast cancer
Padmanaban, V., Krol, I., Suhail, Y., Szczerba, B. M., Aceto, N., Bader, J. S., & Ewald, A. J. (2019) · Nature · doi:10.1038/s41586-019-1526-3 · Cited by 822
The trip of the tip: understanding the growth cone machinery
Lowery, L. A., & Vactor, D. V. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2679 · Cited by 790
Interleukins in cancer: from biology to therapy
Briukhovetska, D., Dörr, J., Endres, S., Libby, P., Dinarello, C. A., & Kobold, S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00363-z · Cited by 781
Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells
Sullivan, N. J., Sasser, A. K., Axel, A. E., Vesuna, F., Raman, V, Ramirez, N., Oberyszyn, T. M., & Hall, B. M. (2009) · Oncogene · doi:10.1038/onc.2009.180 · Cited by 757
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Labani-Motlagh, A., Ashja-Mahdavi, M., & Loskog, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00940 · Cited by 751
Heerboth, S., Housman, G., Leary, M., Longacre, M., Byler, S., Lapinska, K., Willbanks, A., & Sarkar, S. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0048-3 · Cited by 739
Hypoxia: A key regulator of angiogenesis in cancer
Liao, D., & Johnson, R. S. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9066-y · Cited by 721
STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade
Fu, J., Kanne, D. B., Leong, M., Glickman, L. H., McWhirter, S. M., Lemmens, E., Mechette, K., Leong, J. J., Lauer, P., Liu, W., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa4306 · Cited by 720
Tohme, S., Yazdani, H. O., Al-Khafaji, A. B., Chidi, A. P., Loughran, P., Mowen, K., Wang, Y., Simmons, R. L., Huang, H., & Tsung, A. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1591 · Cited by 694
Role of platelets and platelet receptors in cancer metastasis
Schlesinger, M. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0669-2 · Cited by 690
Cao, X. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.8 · Cited by 665
B cell depletion therapies in autoimmune disease: advances and mechanistic insights
Lee, D. S. W., Rojas, O. L., & Gommerman, J. L. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00092-2 · Cited by 658
Inflammation and EMT: an alliance towards organ fibrosis and cancer progression
López‐Novoa, J. M., & Nieto, M. A. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900043 · Cited by 654
Takata, F., Nakagawa, S., Matsumoto, J., & Dohgu, S. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.661838 · Cited by 651
The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase
Hiratsuka, S., Watanabe, A., Sakurai, Y., Akashi-Takamura, S., Ishibashi, S., Miyake, K., Shibuya, M., Akira, S., Aburatani, H., & Maru, Y. (2008) · Nature Cell Biology · doi:10.1038/ncb1794 · Cited by 642
Giri, B., Dey, S., Das, T., Sarkar, M., Banerjee, J., & Dash, S. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.157 · Cited by 635
Mechanisms and Implications of Metabolic Heterogeneity in Cancer
Kim, J., & DeBerardinis, R. J. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.013 · Cited by 606
Regulation of γ-Glutamylcysteine Synthetase Subunit Gene Expression by the Transcription Factor Nrf2
Wild, A. C., Moinova, H. R., & Mulcahy, R. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33627 · Cited by 597
Context-dependent EMT programs in cancer metastasis
Aiello, N. M., & Kang, Y. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181827 · Cited by 584
Stat3 mediates myeloid cell–dependent tumor angiogenesis in mice
Kujawski, M., Kortylewski, M., Lee, H., Herrmann, A., Kay, H., & Yu, H. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35213 · Cited by 581
Chronic Inflammation in Cancer Development
Multhoff, G., Molls, M., & Radons, J. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00098 · Cited by 576
Clambey, E. T., McNamee, E. N., Westrich, J. A., Glover, L. E., Campbell, E. L., Jedlicka, P., de Zoeten, E. F., Cambier, J. C., Stenmark, K. R., Colgan, S. P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202366109 · Cited by 560 · cited 1×
“In the case of Tregs, hypoxia has been shown to upregulate Foxp3 expression through direct HIF-1 α binding to the Foxp3 promoter, promoting both Treg differentiation and immunosuppressive function [64].”
Nrf2 Protein Up-regulates Antiapoptotic Protein Bcl-2 and Prevents Cellular Apoptosis
Niture, S. K., & Jaiswal, A. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.312694 · Cited by 545
Targeting IL-6 trans-signalling: past, present and future prospects
Rose-John, S., Jenkins, B. J., Garbers, C., Moll, J. M., & Scheller, J. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00856-y · Cited by 524
Exploiting the critical perioperative period to improve long-term cancer outcomes
Horowitz, M., Neeman, E., Sharon, E., & Ben-Eliyahu, S. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.224 · Cited by 487
Damage-associated molecular patterns in cancer: a double-edged sword
Hernandez, C., Huebener, P., & Schwabe, R. F. (2016) · Oncogene · doi:10.1038/onc.2016.104 · Cited by 480
The role of IL-6/JAK2/STAT3 signaling pathway in cancers
Huang, B., Lang, X., & Li, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1023177 · Cited by 479
Inflammation and oncogenesis: a vicious connection
Grivennikov, S. I., & Karin, M. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.11.004 · Cited by 456
Targeting cytokine and chemokine signaling pathways for cancer therapy
Yi, M., Li, T., Niu, M., Zhang, H., Wu, Y., Wu, K., & Dai, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01868-3 · Cited by 455
Holmström, K. M., Baird, L., Zhang, Y., Hargreaves, I., Chalasani, A., Land, J. M., Stanyer, L., Yamamoto, M., Dinkova-Kostova, A. T., & Abramov, A. Y. (2013) · Biology Open · doi:10.1242/bio.20134853 · Cited by 448
STING: a master regulator in the cancer-immunity cycle
Zhu, Y., An, X., Zhang, X., Qiao, Y., Zheng, T., & Li, X. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1087-y · Cited by 431
Lou, E., Fujisawa, S., Morozov, A., Barlas, A., Romin, Y., Dogan, Y., Gholami, S., Moreira, A. L., Manova-Todorova, K., & Moore, M. A. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033093 · Cited by 420
Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead
van Hinsbergh, V. W. M., & Koolwijk, P. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvm102 · Cited by 420
Noman, M. Z., Hasmim, M., Messai, Y., Terry, S., Kieda, C., Janji, B., & Chouaib, S. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00207.2015 · Cited by 400
Immunosuppressive cells in tumor immune escape and metastasis
Liu, Y., & Cao, X. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1376-x · Cited by 400
STING Agonists as Cancer Therapeutics
Amouzegar, A., Chelvanambi, M., Filderman, J., Storkus, W., & Luke, J. (2021) · Cancers · doi:10.3390/cancers13112695 · Cited by 395
The ERK and JNK pathways in the regulation of metabolic reprogramming
Papa, S., Choy, P. M., & Bubici, C. (2019) · Oncogene · doi:10.1038/s41388-018-0582-8 · Cited by 381
Tafani, M., Sansone, L., Limana, F., Arcangeli, T., De Santis, E., Polese, M., Fini, M., & Russo, M. A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3907147 · Cited by 373
Yan, H. H., Pickup, M., Pang, Y., Gorska, A. E., Li, Z., Chytil, A., Geng, Y., Gray, J. W., Moses, H. L., & Yang, L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0706 · Cited by 372
Beneficial role of Nrf2 in regulating NADPH generation and consumption
Wu, K. C., Cui, J. Y., & Klaassen, C. D. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr183 · Cited by 368
Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?
Hou, J., Karin, M., & Sun, B. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00459-9 · Cited by 366
Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer
Chouaib, S., Noman, M. Z., Kosmatopoulos, K., & Curran, M. A. (2017) · Oncogene · doi:10.1038/onc.2016.225 · Cited by 365
Chang, S.-H., Liu, C. H., Conway, R., Han, D. K., Nithipatikom, K., Trifan, O. C., Lane, T. F., & Hla, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2535911100 · Cited by 361
Vascular Permeability and Drug Delivery in Cancers
Azzi, S., Hebda, J. K., & Gavard, J. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00211 · Cited by 356
p53 Suppresses the Nrf2-dependent Transcription of Antioxidant Response Genes
Faraonio, R., Vergara, P., Di Marzo, D., Pierantoni, M. G., Napolitano, M., Russo, T., & Cimino, F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605707200 · Cited by 349
Wang, J., Li, D., Cang, H., & Guo, B. (2019) · Cancer Medicine · doi:10.1002/cam4.2327 · Cited by 349
Kartikasari, A. E. R., Huertas, C. S., Mitchell, A., & Plebanski, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.692142 · Cited by 343 · cited 4×
“Moreover, therapies targeting IL-1 β have shown significant potential in malignancies such as multiple myeloma, where they inhibit tumor growth and delay progression to more aggressive disease stages [149].”
InfluentialBates, R. C., & Mercurio, A. M. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-09-0583 · Cited by 343
Bacteria in cancer initiation, promotion and progression
El Tekle, G., & Garrett, W. S. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00594-2 · Cited by 343
Mimeault, M., & Batra, S. K. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12004 · Cited by 330
Colomiere, M., Ward, A. C., Riley, C., Trenerry, M. K., Cameron-Smith, D., Findlay, J., Ackland, L., & Ahmed, N. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604794 · Cited by 320
Inflammation by remote control
Mantovani, A. (2005) · Nature · doi:10.1038/435752a · Cited by 313
Rutkowski, M. R., Stephen, T. L., Svoronos, N., Allegrezza, M. J., Tesone, A. J., Perales-Puchalt, A., Brencicova, E., Escovar-Fadul, X., Nguyen, J. M., Cadungog, M. G., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.11.009 · Cited by 311
The TNF Paradox in Cancer Progression and Immunotherapy
Montfort, A., Colacios, C., Levade, T., Andrieu-Abadie, N., Meyer, N., & Ségui, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01818 · Cited by 305
NRF2 Blockade Suppresses Colon Tumor Angiogenesis by Inhibiting Hypoxia-Induced Activation of HIF-1α
Kim, T.-H., Hur, E.-G., Kang, S.-J., Kim, J.-A., Thapa, D., Lee, Y. M., Ku, S. K., Jung, Y., & Kwak, M.-K. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3007 · Cited by 292
Inflammation-Induced Tumorigenesis and Metastasis
Hibino, S., Kawazoe, T., Kasahara, H., Itoh, S., Ishimoto, T., Sakata-Yanagimoto, M., & Taniguchi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115421 · Cited by 290
Crosstalk between DNA Damage and Inflammation in the Multiple Steps of Carcinogenesis
Kawanishi, S., Ohnishi, S., Ma, N., Hiraku, Y., & Murata, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081808 · Cited by 288
The wound inflammatory response exacerbates growth of pre‐neoplastic cells and progression to cancer
Antonio, N., Bønnelykke‐Behrndtz, M. L., Ward, L. C., Collin, J., Christensen, I. J., Steiniche, T., Schmidt, H., Feng, Y., & Martin, P. (2015) · The EMBO Journal · doi:10.15252/embj.201490147 · Cited by 280
Platelets reduce anoikis and promote metastasis by activating YAP1 signaling
Haemmerle, M., Taylor, M. L., Gutschner, T., Pradeep, S., Cho, M. S., Sheng, J., Lyons, Y. M., Nagaraja, A. S., Dood, R. L., Wen, Y., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00411-z · Cited by 274
Emerging role of tumor cell plasticity in modifying therapeutic response
Qin, S., Jiang, J., Lu, Y., Nice, E. C., Huang, C., Zhang, J., & He, W. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00313-5 · Cited by 268
Impaired liver regeneration in Nrf2 knockout mice: role of ROS‐mediated insulin/IGF‐1 resistance
Beyer, T. A., Xu, W., Teupser, D., auf dem Keller, U., Bugnon, P., Hildt, E., Thiery, J., Kan, Y. W., & Werner, S. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601950 · Cited by 266
Ranneh, Y., Ali, F., Akim, A. M., Hamid, H. A., Khazaai, H., & Fadel, A. (2017) · Applied Biological Chemistry · doi:10.1007/s13765-017-0285-9 · Cited by 250
Yang, K., Wang, X., Zhang, H., Wang, Z., Nan, G., Li, Y., Zhang, F., Mohammed, M. K., Haydon, R. C., Luu, H. H., et al. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2015.144 · Cited by 241
Chen, S., Zhu, H., & Jounaidi, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02005-w · Cited by 234
Chaturvedi, P., Gilkes, D. M., Takano, N., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406655111 · Cited by 226
Burns, J., & Manda, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122755 · Cited by 218
Gain of Nrf2 Function in Non-Small-Cell Lung Cancer Cells Confers Radioresistance
Singh, A., Bodas, M., Wakabayashi, N., Bunz, F., & Biswal, S. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3219 · Cited by 208
The role of inflammation in autoimmune disease: a therapeutic target
Xiang, Y., Zhang, M., Jiang, D., Su, Q., & Shi, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1267091 · Cited by 202
Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition
Zhang, Q., Liu, S., Parajuli, K. R., Zhang, W., Zhang, K., Mo, Z., Liu, J., Chen, Z., Yang, S., Wang, A. R., et al. (2017) · Oncogene · doi:10.1038/onc.2016.240 · Cited by 195
Extracellular Matrices and Cancer-Associated Fibroblasts: Targets for Cancer Diagnosis and Therapy?
Belhabib, I., Zaghdoudi, S., Lac, C., Bousquet, C., & Jean, C. (2021) · Cancers · doi:10.3390/cancers13143466 · Cited by 191
Patrolling the vascular borders: platelets in immunity to infection and cancer
Gaertner, F., & Massberg, S. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0202-z · Cited by 186
Divergent effects of hypoxia on dendritic cell functions
Mancino, A., Schioppa, T., Larghi, P., Pasqualini, F., Nebuloni, M., Chen, I.-H., Sozzani, S., Austyn, J. M., Mantovani, A., & Sica, A. (2008) · Blood · doi:10.1182/blood-2008-02-142091 · Cited by 184
Ban, N., Takahashi, Y., Takayama, T., Kura, T., Katahira, T., Sakamaki, S., & Niitsu, Y. (1996) · PubMed · Cited by 183
Ricciardi, M., Zanotto, M., Malpeli, G., Bassi, G., Perbellini, O., Chilosi, M., Bifari, F., & Krampera, M. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.29 · Cited by 182
Circulating tumor cells: from new biological insights to clinical practice
Gu, X., Wei, S., & Lv, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01938-6 · Cited by 182
Elgundi, Z., Papanicolaou, M., Major, G., Cox, T. R., Melrose, J., Whitelock, J. M., & Farrugia, B. L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01482 · Cited by 176
Chemo-Immunotherapy: A New Trend in Cancer Treatment
Sordo-Bahamonde, C., Lorenzo-Herrero, S., Gonzalez-Rodriguez, A. P., Martínez-Pérez, A., Rodrigo, J. P., García-Pedrero, J. M., & Gonzalez, S. (2023) · Cancers · doi:10.3390/cancers15112912 · Cited by 176
The Epithelial–Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression
Fedele, M., Sgarra, R., Battista, S., Cerchia, L., & Manfioletti, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020800 · Cited by 171
Werno, C., Menrad, H., Weigert, A., Dehne, N., Goerdt, S., Schledzewski, K., Kzhyshkowska, J., & Brune, B. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq088 · Cited by 167
Tweety-Homolog 1 Drives Brain Colonization of Gliomas
Jung, E., Osswald, M., Blaes, J., Wiestler, B., Sahm, F., Schmenger, T., Solecki, G., Deumelandt, K., Kurz, F. T., Xie, R., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3532-16.2017 · Cited by 167
Cho, J.-M., Manandhar, S., Lee, H.-R., Park, H.-M., & Kwak, M.-K. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.10.022 · Cited by 166
The Gastrointestinal Tumor Microenvironment
Quante, M., Varga, J., Wang, T. C., & Greten, F. R. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.03.052 · Cited by 164
Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2
Aleksunes, L. M., Slitt, A. L., Maher, J. M., Augustine, L. M., Goedken, M. J., Chan, J. Y., Cherrington, N. J., Klaassen, C. D., & Manautou, J. E. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.08.022 · Cited by 162
Giles, A. J., Reid, C. M., Evans, J. D., Murgai, M., Vicioso, Y. M., Highfill, S. L., Kasai, M., Vahdat, L. T., Mackall, C. L., Lyden, D. C., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-0204 · Cited by 162
Elsby, R., Kitteringham, N. R., Goldring, C. E., Lovatt, C. A., Chamberlain, M., Henderson, C. J., Wolf, C. R., & Park, B. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301211200 · Cited by 159
Hansen, M. T., Forst, B., Cremers, N., Quagliata, L., Ambartsumian, N., Grum-Schwensen, B., Klingelhöfer, J., Abdul-Al, A., Herrmann, P., Osterland, M., et al. (2014) · Oncogene · doi:10.1038/onc.2013.568 · Cited by 159
White, J. R., Harris, R. A., Lee, S. R., Craigon, M., Binley, K., Price, T., Beard, G. L., Mundy, C. R., & Naylor, S. (2003) · Genomics · doi:10.1016/s0888-7543(03)00215-5 · Cited by 154
Tunneling Nanotubes and Tumor Microtubes in Cancer
Roehlecke, C., & Schmidt, M. H. H. (2020) · Cancers · doi:10.3390/cancers12040857 · Cited by 148
Molecular mechanisms in colitis-associated colorectal cancer
Zhou, R. W., Harpaz, N., Itzkowitz, S. H., & Parsons, R. E. (2023) · Oncogenesis · doi:10.1038/s41389-023-00492-0 · Cited by 139
HO-1 underlies resistance of AML cells to TNF-induced apoptosis
Rushworth, S. A., & MacEwan, D. J. (2008) · Blood · doi:10.1182/blood-2007-07-104042 · Cited by 135
Damage-associated molecular patterns in tumor radiotherapy
Ashrafizadeh, M., Farhood, B., Musa, A. E., Taeb, S., & Najafi, M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106761 · Cited by 134
Lee, S., Lim, M., Kim, M., Yu, C., Yun, Y., Ahn, J., & Song, J. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.038 · Cited by 133
Akt–Girdin Signaling in Cancer-Associated Fibroblasts Contributes to Tumor Progression
Yamamura, Y., Asai, N., Enomoto, A., Kato, T., Mii, S., Kondo, Y., Ushida, K., Niimi, K., Tsunoda, N., Nagino, M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1317 · Cited by 133
Siska, P. J., Singer, K., Evert, K., Renner, K., & Kreutz, M. P. (2020) · Immunological Reviews · doi:10.1111/imr.12846 · Cited by 131
Li, W., Liu, Q., Shi, J., Xu, X. M., & Xu, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1074863 · Cited by 130
Aspirin Use and Risk of Colorectal Cancer Among Older Adults
Guo, C., Ma, W., Drew, D. A., Cao, Y., Nguyen, L. H., Joshi, A. D., Ng, K., Ogino, S., Meyerhardt, J. A., Song, M., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2020.7338 · Cited by 117
Cohen, E. N., Gao, H., Anfossi, S., Mego, M., Reddy, N. G., Debeb, B. G., Giordano, A., Tin, S., Wu, Q., Garza, R. J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132710 · Cited by 116
Hasmim, M., Noman, M. Z., Messai, Y., Bordereaux, D., Gros, G., Baud, V., & Chouaïb, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1302140 · Cited by 115
Jiang, Y.-X., Yang, S.-W., Li, P.-A., Luo, X., Li, Z.-Y., Hao, Y.-X., & Yu, P.-W. (2016) · Oncogene · doi:10.1038/onc.2016.291 · Cited by 114
NF-κB in carcinoma therapy and prevention
Brown, M. S., Cohen, J., Arun, P., Chen, Z., & Waes, C. V. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.9.1109 · Cited by 107
Shimizu, T., Marusawa, H., Endo, Y., & Chiba, T. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02293.x · Cited by 103
Morgillo, F., Dallio, M., Corte, C. M. D., Gravina, A. G., Viscardi, G., Loguercio, C., Ciardiello, F., & Federico, A. (2018) · Neoplasia · doi:10.1016/j.neo.2018.05.002 · Cited by 102
Cao, L., Chen, X., Xiao, X., Ma, Q., & Li, W. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3559 · Cited by 99
Hypoxia-Dependent Angiogenesis and Lymphangiogenesis in Cancer
Schito, L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12734-3_5 · Cited by 98
Lim, S., Becker, A., Zimmer, A., Lu, J., Buettner, R., & Kirfel, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066558 · Cited by 97
Aspirin in the Prevention of Colorectal Neoplasia
Drew, D. A., & Chan, A. T. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-060319-120913 · Cited by 97
Hyperglycaemia-induced chemoresistance of prostate cancer cells due to IGFBP2
Biernacka, K. M., Uzoh, C. C., Zeng, L., Persad, R. A., Bahl, A. K., Gillatt, D. A., Perks, C. M., & Holly, J. M. P. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0077 · Cited by 90
Catanzaro, J. M., Sheshadri, N., Pan, J.-A., Sun, Y., Shi, C., Li, J., Powers, S., Crawford, H. C., & Zong, W. (2014) · Nature Communications · doi:10.1038/ncomms4729 · Cited by 88
Downregulation of HuR as a new mechanism of doxorubicin resistance in breast cancer cells
Latorre, E., Tebaldi, T., Viero, G., Spartà, A., Quattrone, A., & Provenzani, A. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-13 · Cited by 88
Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment
Sosnoski, D. M., Norgard, R. J., Grove, C. D., Foster, S. J., & Mastro, A. M. (2015) · Clinical & Experimental Metastasis · doi:10.1007/s10585-015-9710-9 · Cited by 80
Oxidative Stress and Reprogramming of Lipid Metabolism in Cancers
Li, S., Yuan, H., Li, L., Li, Q., Lin, P., & Li, K. (2025) · Antioxidants · doi:10.3390/antiox14020201 · Cited by 76
Regulation of Blood and Lymphatic Vessels by Immune Cells in Tumors and Metastasis
Mazzone, M., & Bergers, G. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114721 · Cited by 72
Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy
Wu, Y., Pu, X., Wang, X., & Xu, M. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02024-0 · Cited by 72
Imbalance of Clara cell-mediated homeostatic inflammation is involved in lung metastasis
Tomita, T., Sakurai, Y., Ishibashi, S., & Maru, Y. (2011) · Oncogene · doi:10.1038/onc.2011.53 · Cited by 71
Suarez‐Carmona, M., Bourcy, M., Lesage, J., Leroi, N., Syne, L., Blacher, S., Hubert, P., Erpicum, C., Foidart, J., Delvenne, P., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4546 · Cited by 70
Li, X., Zhong, J., Deng, X., Guo, X., Lu, Y., Lin, J., Huang, X., & Wang, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.754196 · Cited by 69
High glucose levels promote the proliferation of breast cancer cells through GTPases
Hou, Y., Zhou, M., Xie, J., Chao, P., Feng, Q., & Wu, J. (2017) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s135665 · Cited by 68
Song, J., Feng, L., Zhong, R., Xia, Z., Zhang, L. R., Cui, L., Yan, H., Jia, X., & Zhang, Z. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22471 · Cited by 64
Crosstalk Between Inflammatory Signaling and Methylation in Cancer
Das, D., Karthik, N., & Taneja, R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.756458 · Cited by 59
Stark, K., Schubert, I., Joshi, U., Kilani, B., Hoseinpour, P., Thakur, M., Grünauer, P., Pfeiler, S., Schmidergall, T., Stockhausen, S., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310262 · Cited by 58
Inflammation and cancer: friend or foe?
Smith, A. D. T., Córdoba-Hernandez, S., Mejía-Guarnizo, L. V., Monroy-Camacho, P. S., & Rodríguez-García, J. A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1385479 · Cited by 57
Neutrophils: Homing in on the myeloid mechanisms of metastasis
Leach, J. D. G., Morton, J. P., & Sansom, O. J. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.12.013 · Cited by 53
Zhu, Y., Cheng, Y., Guo, Y., Chen, J., Chen, F., Luo, R., & Li, A. (2015) · Oncotarget · doi:10.18632/oncotarget.6633 · Cited by 51
Stem cell mutations, associated cancer risk, and consequences for regenerative medicine
Derks, L. L. M., & van Boxtel, R. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.09.008 · Cited by 49
Inflammatory mediators, tumor necrosis factor-α and interferon-γ, induce EMT in human PTC cell lines
Lv, N., Gao, Y., Guan, H., Wu, D., Ding, S., Teng, W., & Shan, Z. (2015) · Oncology Letters · doi:10.3892/ol.2015.3518 · Cited by 46
Berguer, R. (1999) · Archives of Surgery · doi:10.1001/archsurg.134.5.540 · Cited by 45
LI, Y., Zhu, W., LI, J., Liu, M., & WEI, M. (2013) · Oncology Reports · doi:10.3892/or.2013.2748 · Cited by 44
Cell‐to‐cell contact‐mediated regulation of tumor behavior in the tumor microenvironment
Sato, A., Rahman, N. I. A., Shimizu, A., & Ogita, H. (2021) · Cancer Science · doi:10.1111/cas.15114 · Cited by 44
Tunneling nanotubes: The intercellular conduits contributing to cancer pathogenesis and its therapy
Melwani, P. K., & Pandey, B. N. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189028 · Cited by 43
High glucose dephosphorylates serine 46 and inhibits p53 apoptotic activity
Garufi, A., & D’Orazi, G. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-014-0079-4 · Cited by 40
Chen, D., Li, W., Liu, S., Su, Y., Han, G., Xu, C., Liu, H., Zheng, T., Zhou, Y., & Mao, C. (2015) · Scientific Reports · doi:10.1038/srep08604 · Cited by 39
TNF ‐α augments CXCR 2 and CXCR 3 to promote progression of renal cell carcinoma
Sun, K., Sun, G., Wu, Y., Ko, B., Hsu, H., & Wu, S. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12890 · Cited by 38
Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer: The Alliance A011502 Randomized Trial
Chen, W. Y., Ballman, K. V., Partridge, A. H., Hahn, O. M., Briccetti, F., Irvin, W. J., Symington, B. E., Visvanathan, K., Pohlmann, P. R., Openshaw, T. H., et al. (2024) · JAMA · doi:10.1001/jama.2024.4840 · Cited by 34
Breast cancer cells and macrophages in a paracrine-juxtacrine loop
Önal, S., Turker-Burhan, M., Bati‐Ayaz, G., Yanık, H., & Pesen‐Okvur, D. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120412 · Cited by 32
Sato, K., Hikita, H., Myojin, Y., Fukumoto, K., Murai, K., Sakane, S., Tamura, T., Yamai, T., Nozaki, Y., Yoshioka, T., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235573 · Cited by 29
Stress hyperglycemia and enhanced sensitivity to myocardial infarction
Webster, K. A. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0015-0 · Cited by 28
Hager, P., Permert, J., Wikström, A., Herrington, M. K., Östenson, C., & Strömmer, L. (2009) · Metabolism · doi:10.1016/j.metabol.2008.10.021 · Cited by 13
Aspirin Use and Survival Among Patients With Breast Cancer: A Systematic Review and Meta-Analysis
Baker, A., & Kartsonaki, C. (2023) · The Oncologist · doi:10.1093/oncolo/oyad186 · Cited by 11
Exploring Aspirin’s Potential in Cancer Prevention: A Comprehensive Review of the Current Evidence
Durazo, C. I. M., Saji, S. Z., Rawat, A., Villanueva, A. L. M., Bhandari, A., Nurjanah, T., Ryali, N., Martínez, I. G. Z., & Santiago, J. A. C. (2024) · Cureus · doi:10.7759/cureus.70005 · Cited by 7
Editorial: Dual role of inflammatory mediators in cancer immunotherapy
Wang, X., He, J., & Pan, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1229355 · Cited by 3
Metadata
- Authors
- Nishida, A., & Andoh, A.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2025-03-25
- Volume
- 14
- Issue
- 7
- Pages
- 488
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W4408833150
- Cited by
- 270
- References
- 197
- FWCI
- 80.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.